Zawał serca: badanie kliniczne

Kryteria wyłączenia kto nie może wziąć udziału (11)

1. Patient has a known hypersensitivity, contraindication, or allergic reaction to albumin or glutaraldehyde.
2. Patient has a history of bleeding diathesis or coagulopathy.
3. Presence of active infection or contamination in the to be grafted area or the vicinity.
4. Known vasculitis in the to be grafted area.
5. Patient takes immune suppressive medication like prednisone resulting in weakening of the vessel wall.
6. Patient is refusing blood transfusion.
7. Patient or legal representative is unable / unwilling to provide informed consent.
8. Patient is unable to comply with the protocol or proposed follow-up visits.
9. Female patient is pregnant, lactating, or planning pregnancy during the clinical investigation.
10. Female participants of childbearing age must agree to use safe contraception (e.g., intrauterine devices, hormonal contraceptives: contraceptive pills, implants, transdermal patches hormonal vaginal devices, injections with prolonged release, abstinence).
11. Patients who are currently enrolled in another clinical study, or have recently participated in a clinical study, that could potentially interfere with the outcomes or introduce bias into the results of the current study (as determined by the investigator). This includes studies involving investigational drugs, medical devices, or other interventions that could impact the safety, efficacy, or scientific integrity of this study.